DOK1 and breast cancer: All-trans retinoic acid, an endogenous retinoid, has been shown to inhibit the expression of PPARγ and to enhance the expression of DOK1 as it regulates the DOK1/PPARγ pathways thus inhibiting cell proliferation in breast cancer (MCF7 cell line) (74).